Last reviewed · How we verify
NCT06606977
The Impact of Re-training Following Detraining on Greco-Roman Wrestlers
trial testing Training in Heart Rate Variability in 20 participants. Completed in 19 April 2023.
19 April 2023
Quick facts
| Lead sponsor | Tuba Melekoğlu |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 9 August 2021 |
| Primary completion | 19 April 2023 |
| Estimated completion | 19 April 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Training
Conditions studied
- Heart Rate Variability — all drugs for Heart Rate Variability →
- Body Fat — all drugs for Body Fat →
- Wrestling — all drugs for Wrestling →
- Fitness Testing — all drugs for Fitness Testing →
Sponsor
Tuba Melekoğlu
Who can join
19 and older, male only, with Heart Rate Variability or Body Fat. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to analyse the alterations in the physical, physiological, and performance characteristics of the elite Greco-Roman wrestlers who experienced a prolonged period of detraining (14 weeks) as a result of the Covid-19 pandemic. Elite Greco-Roman wrestlers volunteered for the research. Heart rate variability values were measured during the detraining period and for 8 weeks of subsequent training, and then interpreted for training periods with different workloads. Body fat percentage measured during detraining and every 2-week interval during the training period. To determine the fitness status of wrestlers, the Specific Wrestling Fitness test was used before and following the 8-week training period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06606977
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Training
Trials testing the same drug.
- NCT07379073 — Evaluation of a Clinical Support Website for the Management of Common Mental Health Conditions in Primary Care on Compli · NA · not yet recruiting
- NCT06961942 — Enhancing Endoscopic Scoring Consistency and Accuracy in IBD: a Video-based Training Approach · NA · not yet recruiting
- NCT07202182 — Creative Drama-Based Stress Management Program on Stress, Coping, and Emotional Intelligence · NA · completed
- NCT07533838 — The Effect of Simulation-Based ECG Training on ECG Reading Skills of Nursing Students · NA · completed
- NCT06849440 — Effectiveness of Childbirth Preparation Education · NA · completed
Other recruiting trials for Heart Rate Variability
Currently open trials in the same condition.
- NCT06964100 — Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Endurance Performance · recruiting
- NCT06954103 — Mechanisms And Prognosis of Stroke-Heart Syndrome · recruiting
- NCT06915558 — Modulation of the Inflammatory Response in Bariatric Surgery · recruiting
- NCT06797804 — Effectiveness of Information Technology-Assisted Horticultural Therapy Program on Heart Rate Variability, Stress, Depres · NA · recruiting
- NCT06450483 — Compare the Effects of Different AVNS Parameters on Neck Pain, HRV, Balance in Collegiate Atheletes · NA · recruiting
Other Tuba Melekoğlu trials
Trials by the same sponsor.
- NCT06606964 — The Influence of the Lower Limb Components on Genu Varum in Football Players · completed
- NCT06957262 — Effects of Surgical Correction of Nasal Obstruction on Oxygen Uptake and Ventilation Volume · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06606977 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tuba Melekoğlu
- Last refreshed: 23 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06606977.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing